A-Fem Medical Names Steven T. Frankel as Chief Executive Officer
PORTLAND, Ore.--(BW HealthWire)--April 20, 1998--A-Fem Medical Corp. (OTC BB:AFEM - news), announced today the appointment of Steven T. Frankel as chief executive officer, effective immediately.
Frankel will succeed Dr. James E. Reinmuth, who will continue as the company's chairman of the board. In his role as chief executive officer, Frankel will be responsible for A-Fem's three proprietary women's healthcare technologies which include the inSync(TM) miniform, Rapido-Sense(TM) and the PadKit(TM).
Frankel's career in the diagnostics and medical devices industry spans over 30 years. Most recently he was president and chief executive officer of Quidel Corp. [Nasdaq:QDEL - news] responsible for successfully managing the company's transition from a manufacturer of physician office diagnostic test kits for sale by other companies to a branded sales and marketing organization. His efforts established Quidel as the No. 2 test provider.
Prior to joining Quidel, Frankel spent 13 years with Becton, Dickinson and Company as president of various divisions where he built the domestic and international presence for this multinational diagnostic and medical device manufacturer and successfully introduced diagnostic tests and medical devices to the consumer market.
''This is an exciting time for me to assume the leadership of A-Fem, an organization known for its innovation and excellence in women's healthcare technologies which is poised for rapid commercial growth,'' said Frankel.
''Coming from both a small and entrepreneurial testing kit manufacturer as well as large and complex international diagnostics & medical devices company, I intend to apply my varied experience and organizational talents to develop an effective scientific and commercial culture.''
''I also hope to extend both the national and international reach of A-Fem's products which address some of women's most important health concerns today.''
Dr. Reinmuth, chairman of the board stated, ''Steven Frankel's appointment concludes our search for a chief executive officer with a successful track record growing healthcare technology companies. Frankel's 30 years experience with both consumer and diagnostic healthcare companies will provide the strong leadership required to continue the success of our market roll-out of the inSync(TM) miniform and bring our diagnostic development efforts to market.''
Frankel spent his early career in advertising, serving clients such as Johnson & Johnson and American Home Products and was a partner with Turtle Bay Institute, a research and product development practice focused on the consumer market.
A-Fem Medical Corp. is a women's healthcare technologies company. The company has developed three proprietary technology platforms: the Miniform; Rapido-Sense(TM) and the PadKit(TM). A-Fem currently markets the inSync(TM) miniform, an alternative to tampons, pads and liners for light flow protection.
The company is developing point-of-care diagnostics providing quantification of results based on its proprietary Rapido-Sense(TM) technology and is in Phase I clinical studies for its PadKit(TM), a diagnostic sample collection kit targeted to replace the cervical scrape for the Pap test.
For more information, visit the company's website at www.afem.com. |
